From May 9, 2023 to June 30, 2023, the company has repurchased 743,436 shares, representing 1.28% for KRW 4,990.07 million. With this, the company has completed the repurchase of 743,436 shares, representing 1.28% for KRW 4,990.07 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,180 KRW | -15.91% | -19.06% | -24.60% |
01-24 | Elevance Health Offers Stronger-Than-Expected 2024 Earnings Outlook After Fourth-Quarter Beat | MT |
01-24 | Elevance Health Issues Upbeat 2024 Adjusted. Earnings Outlook After 4Q Revenue Gains | DJ |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.60% | 219M | |
-2.32% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
+58.05% | 25.73B | |
-19.56% | 14.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+3.75% | 8.79B |
- Stock Market
- Equities
- A099430 Stock
- News Bio Plus Co., Ltd
- Tranche Update on BioPlus Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.